Genmab A/S ADR (GMAB): Price and Financial Metrics
GMAB Price/Volume Stats
| Current price | $19.62 | 52-week high | $30.63 |
| Prev. close | $19.06 | 52-week low | $18.64 |
| Day low | $19.52 | Volume | 1,315,800 |
| Day high | $19.83 | Avg. volume | 1,522,923 |
| 50-day MA | $20.93 | Dividend yield | N/A |
| 200-day MA | $23.55 | Market Cap | 12.98B |
GMAB Stock Price Chart Interactive Chart >
Genmab A/S ADR (GMAB) Company Bio
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark - internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan. It's a dual listed company with shares traded on the Copenhagen Stock Exchange in Denmark, and on NASDAQ Global Select Market in the US. (Source:Wikipedia)
GMAB Price Returns
| 1-mo | -12.80% |
| 3-mo | -4.66% |
| 6-mo | -19.36% |
| 1-year | -36.36% |
| 3-year | -44.17% |
| 5-year | -2.39% |
| YTD | -5.99% |
| 2024 | -34.45% |
| 2023 | -24.87% |
| 2022 | 7.13% |
| 2021 | -2.71% |
| 2020 | 82.09% |
Loading social stream, please wait...